David B McKinley

Hospital Drug Discount Program Under Lawmakers’ Microscope
House panel to examine legislation Wednesday

Department of Health and Human Services Secretary Alex Azar was to address a conference of hospitals participating in a drug discount program facing Congressional scrutiny. (Sarah Silbiger/CQ Roll Call file photo)

A House panel that has been scrutinizing hospitals’ use of a drug discount program will examine on Wednesday pieces of legislation that stem from members’ concerns over the discounts.

The Energy and Commerce Committee’s oversight panel has had two hearings in the past year on the program, known as 340B. The committee has requested information from hospitals that participate and in January published a report outlining ways the drug discount program could be better run.

As Trump Doubles Down on Coal, West Virginia Lawmakers Are Eyeing Natural Gas
Massive storage and trading hub could be on state’s horizon if Manchin and Capito get their way

Democrat Joe Manchin III and Republican Shelley Moore Capito say their state is in a prime position to host a processing facility. (Bill Clark/CQ Roll Call file photo)

As President Donald Trump readies a strategy to bail out coal and nuclear power plants in part to help reinvigorate Appalachia’s struggling coal industry, West Virginia lawmakers are working to up the state’s participation in the natural gas business.

Their effort to clear a path for the federal government’s financial participation in a massive storage and trading hub for liquids extracted from natural gas could bring more than 100,000 jobs to the state, advocates say. Those liquids are used as feedstock for plastic manufacturing, so it could also turn the state into a major chemical and industrial center as manufacturers look for a steady supply of low-cost raw materials.

Way Out in West Virginia, the Political Vortex
The Mountain State keeps taking the stage for U.S. politics

.

The spectacle of politics and how it fits, or doesn’t, into the nation’s culture. Subscribe to our newsletter here.

West Virginia occupies a unique place in the political universe. A small state, it hosts one of the most tightly contested Senate races of the midterms. But it also finds itself in the political conversation again and again. 

GOP Senate Hopefuls in House Nominate Trump for Nobel Peace Prize
Move comes ahead of key primary battles in Indiana, West Virginia

Rep. Luke Messer, R-Ind., is among the House Republicans who’ve nominated President Donald Trump for the Nobel Peace Prize. (Bill Clark/CQ Roll Call file photo)

Five incumbent House Republicans running for Senate have co-signed a letter nominating President Donald Trump for the Nobel Peace Prize.

It’s a move that could curry favor with the president and his supporters just a week before pivotal primaries in states such as West Virginia and Indiana, two Trump states where GOP candidates are trying to align themselves with the White House.

McKinley ‘on a Mission’ to Help Veterans Hear
Hearing-impaired congressman wants to make it easier for vets to get cochlear implants

Rep. David B. McKinley, R-W.Va., has a visible hearing aid on his right ear. (Bill Clark/CQ Roll Call file photo)

Rep. David B. McKinley is thankful to hear birds chirping in the morning and wants others to have that opportunity.

The West Virginia Republican, who has a cochlear implant in his left ear, has made improving the lives of people like him a personal goal.

Bipartisan Efforts Behind Coal Miner Pension Push
Manchin and Capito lead Senate effort, as miners return to Capitol Hill

West Virginia Sen. Joe Manchin III, center, United Mine Workers of America President Cecil Roberts, center left, and coal miners arrive for a Tuesday press conference on the introduction of legislation to protect miner pension benefits. (Bill Clark/CQ Roll Call)

The coal miners are back.

Last fall, you couldn’t walk through the Capitol’s hallways without running into mine workers wearing camouflage T-shirts.

West Virginia Rep. Evan Jenkins Running for Senate
GOP lawmaker will likely face primary to take on Joe Manchin

West Virginia Rep. Evan Jenkins is running for Senate. (Tom Williams/CQ Roll Call)

Two-term West Virginia Rep. Evan Jenkins announced on Monday he’s running for Senate against Democratic Sen. Joe Manchin in 2018. 

The 3rd District Republican will likely face a primary, with Attorney General Patrick Morrisey also expected to join the GOP field soon. 

Photos of the Week: Science and Pot Protests, a Senate Bus Ride and Kids on the Hill
The week of April 24 as captured by Roll Call's photographers

Archer Somodevilla, son of Getty Images photojournalist Chip Somodevilla, takes photos during Speaker of the House Paul D. Ryan's weekly news conference in the Capitol on Thursday. Thursday was "Take Our Daughters and Sons to Work Day." (Bill Clark/CQ Roll Call)

Spending Shutdown Showdown Fizzling Out
Issues remain, but biggest fights getting knocked out ahead of deadline

From left, Sen. Sherrod Brown, D-Ohio, Reps. David McKinley, R-W.Va., and Mike Doyle, D-Pa., attend a news conference at the House Triangle with the United Mine Workers of America on the Miners Protection Act, which would address expiring health care and pension benefits. Funding the miners’ benefits is one of the remaining issues that could affect the debate over government funding. (Tom Williams/CQ Roll Call)

The first federal funding fight of President Donald Trump’s administration might be ending not with a bang but a whimper. 

House and Senate lawmakers negotiating an omnibus bill to fund the government through the end of September had said the biggest outstanding dispute was over cost-sharing subsidy payments to insurance companies that help lower-income people afford health care under the 2010 overhaul law.

Opinion: Stifling Competition Reduces Access to Affordable Prescriptions
FAST Generics Act easy way to lower costs for patients and taxpayers

Martin Shkreli, former CEO Turing Pharmaceuticals, invoked his Fifth Amendment right against self-incrimination during a House Oversight and Government Reform Committee hearing on "methods and reasoning behind recent drug price increases," in February 2016. Turing had raised the price of a drug used by AIDS and cancer patients  from $13.50 to $750 a pill. (Tom Williams/CQ Roll Call File Photo)

“We don’t want excessive profiteering. But the key word in profiteering is profit.”

When Martin Shkreli told Business Insider this in 2015 he might not have been trying to make a broad statement about perverse incentives in the regulatory status quo. But the statement did belie real problems that arise from a system far more complex than the heroes and villains of many popular media narratives.